相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita
Jeremy Yuen-Chun Teoh et al.
EUROPEAN UROLOGY (2020)
Detection of bladder cancer using urinary cell-free DNA and cellular DNA
Zhenyu Ou et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling
Timothy H. T. Cheng et al.
CLINICAL CHEMISTRY (2019)
Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer
Yanjie Xu et al.
CLINICAL GENITOURINARY CANCER (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers
Dinesh Kumar et al.
PLOS ONE (2017)
Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA
Timothy H. T. Cheng et al.
CLINICAL BIOCHEMISTRY (2017)
Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer
Antonin Brisuda et al.
UROLOGIA INTERNATIONALIS (2016)
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
Karin Birkenkamp-Demtroder et al.
EUROPEAN UROLOGY (2016)
Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer
Ye-Hwan Kim et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2016)
Expression of bone morphogenetic protein-2 and-7 in urinary bladder cancer predicts time to tumor recurrence
Boleslaw Kuzaka et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential
O. E. Bryzgunova et al.
ACTA NATURAE (2015)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
Valentina Casadio et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer
Yuval Tabach et al.
PLOS ONE (2011)
BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells
Liisa Laatio et al.
TUMOR BIOLOGY (2011)
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma
Helena Nord et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidy
Udai S. Dwivedi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis
Matelda Zancan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2009)
HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases
Donna E. Hansel et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Urinary cell-free DNA as a potential tumor marker for bladder cancer
H. W. Chang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2007)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Free DNA in urine: A new marker for bladder cancer? Preliminary data
M Zancan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2005)
Evaluation of measures of urinary albumin excretion in epidemiologic studies
AR Dyer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Quantification of free circulating DNA as a diagnostic marker in lung cancer
G Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
